Clinical Trial Update: Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update of palbociclib, letrozole, and venetoclax in ER and BCL-2 positive breast cancer; trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Palbociclib (palbociclib)
• Venetoclax (venetoclax)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Breast Neoplasm Female | Phase 1 | Status: ACTIVE_NOT_RECRUITING